Pfizer vaccine 95% effective in final analysis, company seeks final safety step | WNT
Pfizer and partner BioNTech said Wednesday the company will apply for FDA emergency authorization “within days,†following the promising final analysis of the Phase 3 trial. WATCH THE FULL EPISODE…